News / Media

Dr. Xiaolin Chen discusses China’s new ‘Made in China’ policy on CGTN Europe

Dr. Xiaolin Chen recently joined CGTN Europe to discuss China’s new policy allowing domestic and foreign firms to qualify as “Made in China” if products undergo substantial local transformation. Effective January and rolled out over five years, it aims to offer equal treatment in government procurement with up to a 20% price preference, encouraging supply chain localization and higher standards. The move aims to reduce market entry barriers and provide foreign investors greater clarity for long-term planning.


The linked content contains Xiaolin Chen's opinion. It should not be regarded as investment advice or recommendation of specific securities. Xiaolin spoke on the 1st of January episode.